Jens Eckstein

Jens Eckstein is an accomplished professional with extensive experience in the health and biotechnology sectors, currently serving as an Investment Partner at Hevolution Foundation and a member of the Board of Directors at Vandria SA. Since June 2019, Jens has held dual roles as a Member of the Board of Advisors and Managing Partner at Apollo Health Ventures, which focuses on developing interventions to enhance healthy lifespan. Jens also acts as President and a Board member at Galilei Biosciences, while advising and chairing Booster Therapeutics and Refoxy Pharma. Additional engagements include advisory roles at Thymofox and bosWell, and serving as a Non-Executive Director at Imugene Limited. Jens is a Kauffman Fellow and has an academic background that includes a Ph.D. in Biological Chemistry from the University of Konstanz and postdoctoral training at the University of California, San Francisco.